Literature DB >> 1930749

Immunohistochemical mapping of neurophysins and calcitonin gene-related peptide in the human brainstem and cervical spinal cord.

J W Unger1, W Lange.   

Abstract

Our study investigates the distribution of neurophysins (Nph), proteins that are part of the precursors for vasopressin and oxytocin, and calcitonin gene-related peptide (CGRP) in the human brainstem by immunohistochemistry. Both peptides were found in discrete regions of the human hindbrain. Nph could be demonstrated exclusively in fibers and punctate perineural varicosities that were travelling within the mesencephalic central gray, substantia nigra, as well as locus coeruleus, medial longitudinal fascicle, raphe, nucleus of the solitary tract, lateral reticular nucleus and area postrema. A few varicosities were seen in the substantia gelatinosa of the spinal trigeminal tract and its continuation into the dorsal horn of the cervical spinal cord. In contrast to these observations. CGRP-immunoreactive fibers were found to be densest in the spinal tract of the trigeminal nerve and the dorsal horn of the spinal cord. In addition, fibers and varicosities could be demonstrated in numerous distinct brain regions, such as locus coeruleus and subcoeruleus, solitary tract, cuneate nucleus, raphe and periaqueductal gray. CGRP-immunoreactivity was also present in perikarya in the ventral horn of the spinal cord, as well as motor nuclei of cranial nerves, i.e., hypoglossal nucleus, ambiguous nucleus. Our results suggest that Nph-immunoreactivity in the human brainstem may be present predominantly within long fiber projections from hypothalamic neurosecretory nuclei, in analogy to data obtained from rodents, whereas CGRP may play a role in the branchiomotor system as well as in intrinsic or extrinsic projections involved in autonomic regulation and integration of sensory information.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930749     DOI: 10.1016/0891-0618(91)90020-d

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  7 in total

1.  Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.

Authors:  Sajedeh Eftekhari; Lars Edvinsson
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

Review 2.  CGRP mechanism antagonists and migraine management.

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

Review 3.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

4.  Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level.

Authors:  Sajedeh Eftekhari; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2011-11-10       Impact factor: 3.288

5.  Acupuncture modulates the abnormal brainstem activity in migraine without aura patients.

Authors:  Zhengjie Li; Fang Zeng; Tao Yin; Lei Lan; Nikos Makris; Kristen Jorgenson; Taipin Guo; Feng Wu; Yujie Gao; Mingkai Dong; Mailan Liu; Jie Yang; Ying Li; Qiyong Gong; Fanrong Liang; Jian Kong
Journal:  Neuroimage Clin       Date:  2017-05-22       Impact factor: 4.881

6.  TRPV1-Like Immunoreactivity in the Human Locus K, a Distinct Subregion of the Cuneate Nucleus.

Authors:  Marina Del Fiacco; Maria Pina Serra; Marianna Boi; Laura Poddighe; Roberto Demontis; Antonio Carai; Marina Quartu
Journal:  Cells       Date:  2018-07-08       Impact factor: 6.600

7.  The human cuneate nucleus contains discrete subregions whose neurochemical features match those of the relay nuclei for nociceptive information.

Authors:  Marina Del Fiacco; Marina Quartu; Maria Pina Serra; Marianna Boi; Roberto Demontis; Laura Poddighe; Cristina Picci; Tiziana Melis
Journal:  Brain Struct Funct       Date:  2013-08-23       Impact factor: 3.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.